According to Judge Kenneth Bell, there is a lack of evidence to conclude that Merck willingly misrepresented the safety of ...

Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S ...

Merck (MRK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The measles outbreak is surging in West Texas, especially in under-vaccinated communities, but it’s not just coverage with ...

The program will offer one dose of the 13-valent pneumococcal conjugate vaccine (PCV13) and one dose of the 23-valent pneumococcal polysaccharide vaccine (PPV23). PCV13, a safe 13-serotype inactivated ...

A conjugate vaccine is a substance that is composed of a polysaccharide antigen fused (conjugated) to a carrier molecule. This enhances the stability and the effectiveness of the vaccine.

Adults 19 and older with sickle cell disease who have not received a pneumococcal conjugate vaccine (PCV) should receive a single dose of either Vaxneuvance (PCV15), Prevnar 20 (PCV20), or Capvaxive ...

Merck’s new 21-valent pneumococcal conjugate vaccine, Capvaxive, and Winrevair have the potential to generate significant revenues for Merck over the long term. Both the products are witnessing ...

Merck MRK stock has declined 7.8% in the past month — in roughly the span after it announced fourth-quarter 2024 results and provided a disappointing guidance for 2025. On Feb. 4, Merck announced its ...

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other ...

Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...